Latest Breaking News On - Sirona capital - Page 1 : comparemela.com

Lose Fat, Not Muscle: Next Test for Lilly s Zepbound Pairs It With BioAge Drug

In preclinical testing, combining BioAge Labs’ experimental drug with Eli Lilly weight drug Zepbound led to greater weight loss compared with Zepbound alone. Now the company plans to run a Phase 2 study to see if it can replicate those results in humans.

United kingdomRedwood cityUnited statesChapel hillThousand oaksLatigo biotherapeuticsKnopp biosciencesAscendis transconAndreessen horowitzKristen fortneyEli lilly zepboundEli lillyAscendis pharmaSudo biosciencesMarshall waceSv health investors

Synnovation Therapeutics Launches with $102 Million to Advance Clinical-Stage Pipeline of Precision Therapies Targeting Highly Validated Disease Pathways

Synnovation Therapeutics Launches with $102 Million to Advance Clinical-Stage Pipeline of Precision Therapies Targeting Highly Validated Disease Pathways
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

Reid huberPhillip liuLiangxing wuRalphf hirschmanThilo schroederWenqing yaoJudith liJigar raythathaKevin ohayerHead of clinical developmentTherapeutics launchesAdvance clinical stage pipelineThird rock venturesLilly asia venturesSirona capitalCormorant asset

This Startup Fights Bladder Cancer With A Genetically Engineered Virus

CG Oncology, led by Forbes 30 Under 30 alum Arhtur Kuan, has developed a genetically engineered virus to treat bladder cancer.

United statesArthur kuanAlex yeungGary steinbergRush medical collegeCrush medicalHong kong based ally bridgeChief operating officerAcorn bioventuresSirona capitalForesite capital

Money Moves: ArriVent Biopharma raised another megaround

Plus, investments in car subscription startup Go and online safety-focused Kidas, grants for diversity in tech and city gov safety projects, and the Science Center wrapped its Phase 1 Ventures fund.

United statesCity of philadelphiaNew jerseyDepartment of transportationFort lauderdaleFort worthUniversity cityTribaja googleKida protectmeTiffany wilsonShannon moralesBing yaoHeath naquinCarlton williamsMichael beauchampArrivent biopharma

Sequoia China joins US-based $155m ArriVent Biopharma s Series B round

The firm has so far raised a total of $300 million.

Zhang leiArrivent biopharmaAllist pharmaceuticalsHillhouse capital groupUnicorn capital partnersPennsylvania based arrivent biopharmaSofinnova investmentsGeneral catalystCatalio capital managementShanghai healthcare capitalSequoia chinaTerra magnum capital partnersUnicorn capital partners limitedInfinitum asset managementLilly asia venturesOctagon capital advisors